A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial

por de Velasco, Guillermo, Carril-Ajuria, Lucia, Guerrero-Ramos, Felix, Alonso-Gordoa, Teresa, Rodríguez-Moreno, Juan F., Carretero, Alberto, Martin-Soberon, Maricruz, de la Rosa-Kehrmann, Federico, Castellano, Daniel
Publicado 2020

Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial

por de Velasco, Guillermo, Carril-Ajuria, Lucia, Guerrero-Ramos, Felix, Alonso-Gordoa, Teresa, Rodríguez-Moreno, Juan F., Carretero, Alberto, Martin-Soberon, Maricruz, de la Rosa-Kehrmann, Federico, Castellano, Daniel
Publicado 2022

Adjuvant dabrafenib and trametinib for patients with resected BRAF-mutated melanoma: DESCRIBE-AD real-world retrospective observational study

por Manzano, José L., Martin-Liberal, Juan, Fernández-Morales, Luis A., Benítez, Gretel, Medina Martínez, Javier, Quindós, María, García-Castaño, Almudena, Fernández, Ovidio, Simo, Rocío V., Majem, Margarita, Bellido, Lorena, Ayala de Miguel, Pablo, Campos, Begoña, Espinosa, Enrique, Macías Cerrolaza, José A., Gil-Arnaiz, Irene, Lorente, David, Rodriguez-Lescure, Alvaro, Perez, Victor N., López Castro, Rafael, Gramaje, María G., Puértolas, Teresa, Rodriguez Moreno, Juan F., Espasa Font, Laia, Belaustegui Ferrández, Guillermo, Cerezuela-Fuentes, Pablo
Publicado 2023